Stimulants
RCORP Grantee Data Collection Resources (Psychostimulant Cohort)
RCORP- Psychostimulant Support Program – Behavioral Health Disparities Impact Statement Webinar Materials
RCORP-Psychostimulant Support (RCORP-PS) Guidance Modules (B)
We are pleased to announce RCORP-Psychostimulant Support (RCORP-PS) guidance modules are now available. Module B – Program Implementation Guidance for Treatment and Recovery Core Activities shares information regarding the three required treatment and recovery core activities grantees will put into practice. You can access them below.
RCORP-Psychostimulant Support (RCORP-PS) Guidance Modules (A)
We are pleased to announce RCORP-Psychostimulant Support (RCORP-PS) guidance modules are now available. Module A – Program Implementation Guidance for Prevention Core Activities provides grantees with information about how to implement the three required prevention core activities. You can access them below.
RCORP 2021 (Region 5 Meeting): Stimulants 2021, An Update—Clinical Issues and Treatments
RCORP 2021 (Region 5 Meeting): Effective Harm Reduction Strategies for People Who Actively Use Opioids and/or Psychostimulants
Overamping
Eastern Regional Meeting (Regions 1, 2 & 3): Effective Harm Reduction Strategies for People Who Actively Use Opioids and/or Psychostimulants
Effective Harm Reduction Strategies for People Who Actively Use Opioids and/or Psychostimulants
Participants will learn evidenced-based harm reduction strategies to keep people who use opioids and psychostimulants alive with reduced disease burden. Presenters will discuss methods of engaging people who actively use opioids and/or psychostimulants, harm reduction interventions, overdose prevention and response, overamping prevention and response, and linkages to care.
Robert Childs, MPH, JBS International
Christine Rodriguez, MPH, Vital Strategies